Genmab A/S (GMAB)
32.96
+1.64
(+5.22%)
USD |
NASDAQ |
Jan 21, 16:00
32.96
0.00 (0.00%)
After-Hours: 17:57
Genmab EPS Diluted (Quarterly): 0.6431 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.0993 |
| Krystal Biotech, Inc. | 2.660 |
| Novo Nordisk A/S | 0.7044 |
| Ascendis Pharma A/S | -1.173 |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 399.21M |
| Revenue (Quarterly) | 1.017B |
| Total Expenses (Quarterly) | 618.23M |
| Enterprise Value | 16.00B |
| Gross Profit Margin (Quarterly) | 94.32% |
| Profit Margin (Quarterly) | 39.24% |
| Earnings Yield | 7.14% |
| Operating Earnings Yield | 6.38% |
| Normalized Earnings Yield | 7.178 |